Research Article

Circulating microRNAs and Kallikreins before and after Radical Prostatectomy: Are They Really Prostate Cancer Markers?

Table 1

Demographic characteristics of the patients enrolled in the present study.

Clinical parametersPCa
Median age (range)62 (54–63 ys)
Median PSA (range)5.55 (3.11–9 ng/mL)
Clinical stage
 T1c21 (55.3%)
 T2a6 (15.8%)
 T2b3 (7.9%)
 T2c8 (21%)
Pathological Gleason score
 6 ( )20 (52.6%)
 7 ( )2 (5.3%)
 7 ( )12 (31.6%)
 8 ( )4 (10.5%)
Lymph node involvement6 (15.8%)
Pathological stage
 T2a6 (15.8%)
 T2b2 (5.3%)
 T2c24 (63.1%)
 T3a4 (10.5%)
 T3b2 (5.3%)